Documentos relacionados

1. Hypertension in Women and Pregnancy.
2. Postpartum readmission for hypertension and pre-eclampsia: development and validation of a predictive model.
3. The impact of pre-eclampsia definitions on the identification of adverse outcome risk in hypertensive pregnancy - analyses from the CHIPS trial (Control of Hypertension in Pregnancy Study).
4. Animal models of preeclampsia: investigating pathophysiology and therapeutic targets.
5. Analyzing Preeclampsia as the Tip of the Iceberg Represented by Women with Long-Term Cardiovascular Disease, Atherosclerosis, and Inflammation.
6. Hypertension in Pregnancy: What We Now Know.
7. Emerging concepts since the Chronic Hypertension and Pregnancy trial.
8. Body of Evidence in Favor of Adopting 130/80 mm Hg as New Blood Pressure Cut-Off for All the Hypertensive Disorders of Pregnancy.
9. Emerging Therapeutic Potential of Mesenchymal Stem/Stromal Cells in Preeclampsia.
10. Cellular Immunotherapy in Mice Prevents Maternal Hypertension and Restores Anti-Inflammatory Cytokine Balance in Maternal and Fetal Tissues.